← Back to headlines
Gilead's Trodelvy Approved for New Breast Cancer Indications
Gilead's drug Trodelvy has received approval for new indications in the treatment of breast cancer, expanding its potential use for patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
